Ampio Pharmaceuticals Navigation
  • About Us
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Clinical Trial
    • About the Study
    • Am I Eligible?
  • Pipeline
    • Overview
    • Ampion
    • About Osteoarthritis
    • Optina
    • About Diabetic Macular Edema
  • Partnering
  • Investors
    • Stock Information
    • Financial Filings
    • Corporate Governance
    • Presentations & Media
  • News
    • Latest News
    • Publications
  • Contact Us
  • About Us
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Clinical Trial
    • About the Study
    • Am I Eligible?
  • Pipeline
    • Overview
    • Ampion
    • About Osteoarthritis
    • Optina
    • About Diabetic Macular Edema
  • Partnering
  • Investors
    • Stock Information
    • Financial Filings
    • Corporate Governance
    • Presentations & Media
  • News
    • Latest News
    • Publications
  • Contact Us
Home Investors Presentations & Media

Presentations & Media

Ampio – Management Presentation 2020

Audio Recording of the Ampio Annual Investor Meeting held on Saturday, December 14, 2019

Real Time Quote

SUBSCRIBE

Get email notifications of the latest Ampio news.
Loading

Latest News

AMPIO BEGINS PHASE 1 CLINICAL TRIAL OF INHALED AMPION FOR COVID-19 PATIENTS WITH RESPIRATORY DISTRESS

October 28, 2020

Ampio Pharmaceuticals, Inc. to Present at the ROTH Capital Healthcare Event “COVID-19 Therapeutics in Development”

October 27, 2020

Ampio Presents at Roth Capital Partners 2020 MedTech Innovation Forum Focusing on COVID-19 Clinical Trial Activities

October 26, 2020
member-logo-85

© 2020 Ampio Pharmaceuticals Inc.

373 Inverness Parkway, Suite 200
Englewood, CO 80112 USA

Privacy Policy

Main office: +1 720 437 6500
Fax: +1 720 437 6501

General email inquiries: info@ampiopharma.com

  • Home
  • About Us
  • Clinical Trial
  • Pipeline
  • Partnering
  • Investors
  • News
  • Contact Us